Analysts predict a revenue drop and higher losses per share ...

Analysts predict a revenue drop and higher losses per share for Amylyx Pharmaceuticals, indicating slower sales growth than the market, potentially causing market wariness.

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Analysts Are More Bearish Than They Used To Be

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

Translate

Report

4299 Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

3201Followers

0Following

7971Visitors